Bank of Montreal’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-6,660
| Closed | -$22K | – | 4993 |
|
|
2018
Q3 | $22K | Sell |
6,660
-19,211
| -74% | -$69.3K | ﹤0.01% | 3685 |
|
|
2018
Q2 | $98K | Sell |
25,871
-95,229
| -79% | -$464K | ﹤0.01% | 3133 |
|
|
2018
Q1 | $495K | Buy |
121,100
+90,000
| +289% | +$419K | ﹤0.01% | 2231 |
|
|
2017
Q4 | $144K | Sell |
31,100
-4,282
| -12% | -$23.6K | ﹤0.01% | 2836 |
|
|
2017
Q3 | $251K | Sell |
35,382
-35,085
| -50% | -$252K | ﹤0.01% | 2570 |
|
|
2017
Q2 | $509K | Hold |
70,467
| – | – | ﹤0.01% | 2262 |
|
|
2017
Q1 | $434K | Buy |
+70,467
| New | +$386K | ﹤0.01% | 2150 |
|
|
2016
Q2 | – | Sell |
-2,703
| Closed | -$13K | – | 4456 |
|
|
2016
Q1 | $13K | Sell |
2,703
-319
| -11% | -$1.27K | ﹤0.01% | 3542 |
|
|
2015
Q4 | $16K | Sell |
3,022
-9,736
| -76% | -$46.3K | ﹤0.01% | 3477 |
|
|
2015
Q3 | $45K | Buy |
12,758
+12,558
| +6,279% | +$84.1K | ﹤0.01% | 2966 |
|
|
2015
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 3793 |
|
|
2015
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3740 |
|
|
2014
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 3799 |
|
|
2014
Q3 | $3K | Sell |
200
-2,230
| -92% | -$34.1K | ﹤0.01% | 3878 |
|
|
2014
Q2 | $37K | Buy |
2,430
+2,230
| +1,115% | +$31.6K | ﹤0.01% | 3339 |
|
|
2014
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3880 |
|
|
2013
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 3611 |
|
|
2013
Q3 | $2K | Sell |
200
-50
| -20% | -$445 | ﹤0.01% | 3692 |
|
|
2013
Q2 | $2K | Buy |
+250
| New | +$1.95K | ﹤0.01% | 3564 |
|
Bank of Montreal's KERX Position: Q4 2018 in Review
Bank of Montreal sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,660 shares — an estimated $22K sold.
Bank of Montreal first reported a position in KERX in Q2 2013 and held it in 19 quarters. The position peaked at $509K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Bank of Montreal reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Bank of Montreal sold 6,660 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $22K.
- Bank of Montreal first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 19 quarters.
- Bank of Montreal's Keryx Biopharmaceuticals Inc position peaked at $509K in Q2 2017.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Bank of Montreal's 13F filing for Q4 2018, filed 22 Jan 2019.